The paradigm shift in the diagnosis of Alzheimer's disease
JI Yong
WANG Pan
Abstract：The diagnostic criteria for Alzheimer's disease(AD)has undergone the fundamental shift,moving from clinical symptom-based approach to the focus on precise pathological changes.This paper focuses on the diagnostic advances and future prospects of cerebrospinal fluid biomarkers,blood biomarkers,and molecular imaging biomarkers for Alzheimer's disease,aiming to provide guidance for the early and accurate diagnosis of the disease.
Keywords：Alzheimer diseaseAmyloid beta-peptidesTau proteinsPositron-emission tomographyReview
Publication Date：2026-02-25
Online Publishing Date：2026-04-07(First online date of this platform, not the publication date of the document)
Pages：4( 105-108 )